The Effect of PPI in Preventing Gastroesophageal Reflux Disease of Seafarers

NCT04696783 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

92

Enrollment

OTHER

Sponsor class

Conditions

Gastroesophageal Reflux Disease

Interventions

DRUG: Esomeprazole Magnesium Enteric-coated Tablets
BEHAVIORAL: Lifestyle adjustment

Sponsor

Fifth Affiliated Hospital, Sun Yat-Sen University